Company
Nanogrow
Leveraging the Power of Single-domain Antibodies with localized delivery for a healthier future.
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Nanogrow is developing a new generation of biological treatments that combine the efficacy of antibodies with the safety of localized delivery, expanding what traditional mAbs can do. Their unique nanobody platform integrates natural and synthetic libraries with advanced computational tools—AI, structural modeling, and biophysical analysis—to design optimal candidates and tailor delivery to each therapeutic need. This approach improves binding, stability, and manufacturability while reducing development time and costs.
Loading relationship preview